ArticleCurrent medical science2023

Efficacy of Bispecific Antibody Targeting EpCAM and CD3 for Immunotherapy in Ovarian Cancer Ascites: An Experimental Study.

Yi-Nuo Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.